What is Edwards Lifesciences Corp's share price today?
Edwards Lifesciences Corp (EW) share price today is $100.78 as of November 6, 2026 at 2:29 AM IST. The stock touched a day high of $104.00 and a day low of $98.86.What exchange does Edwards Lifesciences Corp stock trade on, and under what ticker symbol?
Edwards Lifesciences Corp stock trades on NYSE under the ticker symbol EW.What is Edwards Lifesciences Corp's market capitalization?
Edwards Lifesciences Corp's market capitalization is $54.86B as of November 6, 2026 at 2:29 AM IST.What is Edwards Lifesciences Corp's price-to-earnings (P/E) ratio?
Edwards Lifesciences Corp's price-to-earnings (P/E) ratio is 56.66 as of November 5, 2026.What is Edwards Lifesciences Corp's price-to-book (P/B) ratio?
Edwards Lifesciences Corp's price-to-book (P/B) ratio is 4.99 as of November 5, 2026.Can Indian investors buy Edwards Lifesciences Corp shares?
Yes, You can buy Edwards Lifesciences Corp shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Edwards Lifesciences Corp shares from India?
Indian investors can buy Edwards Lifesciences Corp shares in three steps: 1. Search Edwards Lifesciences Corp on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Edwards Lifesciences Corp shares for Indian investors?
Since Edwards Lifesciences Corp trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Edwards Lifesciences Corp shares via Tickertape?
Indian investors can start investing in Edwards Lifesciences Corp (EW) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0992 shares at the current price of $100.78.
$
₹
$100.781.42% (+1.41)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
56.66
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
4.99
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$1.68
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
1.92
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
15.43%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 30 analysts reports
Buy23 analysts
Hold7 analysts
Sell0 analyst
Price Upside
+2.51%
Earnings Growth
+17.17%
Rev. Growth
+11.43%
Company Profile
Company Profile
P/E Ratio
40.97
40.97
1Y Return
7.25%
7.25%
Buy Reco %
82.14
82.14
P/E Ratio
38.09
38.09
1Y Return
10.7%
10.7%
Buy Reco %
83.33
83.33
P/E Ratio
53.29
53.29
1Y Return
12.11%
12.11%
Buy Reco %
76.47
76.47
P/E Ratio
24.41
24.41
1Y Return
15.97%
15.97%
Buy Reco %
66.66
66.66
P/E Ratio
32.68
32.68
1Y Return
6.31%
6.31%
Buy Reco %
76.66
76.66
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$99.37Baseline
Analyst Target - 1 year
Target$101.87+2.51%
All values in $
2026
Current$99.37Baseline
Analyst Target - 1 year
Target$101.87+2.51%
All values in $
Revenue Forecast
Revenue Forecast
Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.
The next fiscal year's mean estimate implies 11.43% growth, versus a trailing 3-year CAGR of 4.08%.
2025
Current$6.06Baseline
Forecast for Dec 2026
High$6.83+12.66%
Average$6.76+11.43%
Low$6.66+9.83%
All values in $ Billion
2025
Current$6.06Baseline
Forecast for Dec 2026
High$6.83+12.66%
Average$6.76+11.43%
Low$6.66+9.83%
All values in $ Billion
Earnings Per Share Forecast
Earnings Per Share Forecast
Higher earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.
The next fiscal year's mean estimate implies 17.17% growth, versus a trailing 3-year CAGR of 1.06%.
2025
Current$2.56Baseline
Forecast for Dec 2026
High$3.05+19.14%
Average$3+17.17%
Low$2.96+15.62%
All values in $
2025
Current$2.56Baseline
Forecast for Dec 2026
High$3.05+19.14%
Average$3+17.17%
Low$2.96+15.62%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
| Financial Year | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.38 | 1.35 | 1.38 | 1.41 | 1.53 | 1.55 | 1.56 | 1.64 | 1.74 | 1.71 |
Gross Profit | 1.08 | 1.09 | 1.09 | 1.11 | 1.18 | 1.20 | 1.22 | 1.28 | 1.35 | 1.34 |
| Net Income | 0.36 | 3.07 | 0.38 | 0.35 | 0.32 | 0.29 | 0.09 | 0.38 | 0.24 | 0.30 |
| Net Profit Margin | 26.24% | 226.72% | 27.82% | 25.34% | 21.52% | 18.74% | 5.81% | 23.09% | 13.89% | 17.92% |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareMedical Devices
HealthcareMedical Devices
Valuation
Returns
Forecast
Compare valuation on Screener| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp | 56.66 | 4.99 | 1.92 |
| Abbott Laboratories | 40.97 | 3.72 | 1.57 |
| Danaher Corporation | 38.09 | 2.98 | 1.29 |
Price Comparison
Price Comparison
Compare EW with any stock or ETFCompare EW with any stock or ETF
Comparing from
EW
ABT
DHR
The 12-month consensus target implies 2.51% growth, versus a trailing 3-year CAGR of 13.98%.